-
-
Call more information
660-596-2224 -
Determined to cement access to reliable and safe sources for crucial IV drug admixtures, a growing number of hospitals are bringing production of compounded sterile products (CSPs) in-house and turning their backs on external compounding pharmacies. Such far-reaching decisions reflect the lingering distrust of outsourced CSPs, according to several administrators from hospitals that have made […]
Read MoreThe goal of any perioperative protocol is to improve patient outcomes after surgery. In colorectal surgery, however, there is minimal evidence to support traditional perioperative practices, such as bowel preparation and fasting before surgery. In the mid-1990s, this gap in understanding prompted a group of surgeons, led by Henrik Kehlet, MD, PhD, from Copenhagen, to […]
Read MoreHospital CEOs should focus less on talking about an organization’s cultureand more on the elements that make up a hospital’s culture, such as mindset, methods, strategies and structures, former physician John Kenagy, M.D., founder of Kenagy & Associates. Health system leaders must develop adaptive concepts that support and foster a culture that can go with […]
Read MoreAuthors: Pugh ME et al., Chest 2014 Jul 146:159 Left heart disease was a more likely cause of pulmonary hypertension in an older population. Pulmonary hypertension is being diagnosed in a growing number of older adults, but whether this trend is due to pulmonary arterial hypertension (PAH; pulmonary hypertension not secondary to left heart disease […]
Read MoreThe US Food and Drug Administration (FDA) has approved naloxegol (Movantik, AstraZeneca Pharmaceuticals), a peripherally acting opioid receptor antagonist, for the treatment of opioid-induced constipation (OIC) in adults with chronic noncancer pain. OIC is a common adverse effect of opioid use. An estimated 40% to 80% of patients receiving long-term opioid therapy experience OIC, which […]
Read More